Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. - Wikidata - awgldk - TriplyDB

Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.

Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.

http://www.wikidata.org/entity/Q35087329

about

Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer.

P2860

Q35668911-0B6DF7C2-056E-4043-A5AB-5F260876010C Q37158881-2F0FD986-30D4-49F9-B2A7-3CC27E51AB2C

P2860

Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.

http://www.wikidata.org/entity/Q35087329

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@ast

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@en

type

label

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@ast

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@en

prefLabel

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@ast

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@en

P1433

Q35087329-B1A1FB53-8822-43F3-8AB5-2BE15150AD04

P1476

Q35087329-48BD6897-A0E8-46A7-BC71-344427E8B729

P2093

Q35087329-0EAE0FDE-EF94-43CE-80F0-50EFA5492FFC

Q35087329-D75D0F22-0A69-4DA1-9186-7F10E3470BCF

P2860

Q35087329-097E6E01-E3E3-42F6-90EB-876A0BD37F79

Q35087329-3AB3630A-D78A-4F6C-BF0A-E9623EF71D49

Q35087329-4355C143-AD05-4F5D-8894-9FB79471F491

Q35087329-5C1B61DE-361C-4BA3-86FB-BD11C1B5085A

Q35087329-88F33132-D546-4B38-B8DA-19F5734B11F4

Q35087329-A2469F25-5118-4F3C-883E-0C8157BCF1BB

Q35087329-A4E9776D-BEE1-45FD-93B8-31BDB6772AD4

Q35087329-A84E80A6-32E1-4551-9CE4-08BC2A61A8BC

Q35087329-ACBD454D-AF92-4363-978A-DD4A2DE63ADF

Q35087329-D0A7F847-65B2-4966-B344-D1D3977202EC

P304

Q35087329-0DBDC673-6B1F-467E-8B99-A813A8AD6F58

P31

Q35087329-D65DC9C1-E3A6-4D52-B4F8-A57A7697DBE6

P356

Q35087329-5E1D8C41-A0C5-4D64-865D-1124409F6B36

P433

Q35087329-5502AB98-BE37-4C70-9BE6-4F85A105C429

P478

Q35087329-EB5A398C-A57A-446C-A72B-4C1D04529E66

P577

Q35087329-316D0C97-447D-42B7-BDA5-84F0C6BC3FD4

P698

Q35087329-E5F4253D-A0FE-49EA-80B9-5DB35AF62A05

P356

P1433

Cancer Investigation

P1476

Taxanes in the treatment of ad ...... (NSCLC): recent developments.

@en

P2093

George R Simon

http://www.w3.org/2001/XMLSchema#string

Paul A Bunn

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer.

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.

Preliminary result of phase II study of paclitaxel and cisplatin chemotherapy for advanced non-small-cell lung cancer in Chinese patients.

Cancer statistics, 2000.

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

Synthesis and biological properties of C12,13-cyclopropyl-epothilone A and related epothilones.

Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition.

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.

P304

87-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/CNV-120005919

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12643013

http://www.w3.org/2001/XMLSchema#string